These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24179015)

  • 21. [The importance of overweight and obesity for the development and progression of renal diseases].
    Klassen A; Bahner U; Sebekova K; Heidland A
    Dtsch Med Wochenschr; 2004 Mar; 129(11):579-82. PubMed ID: 14997412
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic syndrome and kidney disease.
    Ritz E
    Blood Purif; 2008; 26(1):59-62. PubMed ID: 18182798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overweight, obesity and metabolic alterations in chronic kidney disease.
    Zoccali C
    Prilozi; 2009 Dec; 30(2):17-31. PubMed ID: 20087247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
    Regolisti G; Buzio C; Cavatorta A; De Martin L; Cavalli R; Perazzoli F; Coghi P; Cabassi A; Pucci F; Borghetti A
    Acta Biomed Ateneo Parmense; 1992; 63(1-2):163-73. PubMed ID: 1340661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of hypertension, diabetes mellitus, obesity and other factors on kidney haemodynamics.
    Tsioufis C; Tatsis I; Thomopoulos C; Wilcox C; Palm F; Kordalis A; Katsiki N; Papademetriou V; Stefanadis C
    Curr Vasc Pharmacol; 2014 May; 12(3):537-48. PubMed ID: 23305375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salt intake and kidney disease.
    Boero R; Pignataro A; Quarello F
    J Nephrol; 2002; 15(3):225-9. PubMed ID: 12113591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renal consequences of obesity].
    Laville M
    Nephrol Ther; 2011 Apr; 7(2):80-5. PubMed ID: 21208837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein is associated with renal function abnormalities in a non-diabetic population.
    Stuveling EM; Hillege HL; Bakker SJ; Gans RO; De Jong PE; De Zeeuw D
    Kidney Int; 2003 Feb; 63(2):654-61. PubMed ID: 12631131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial.
    Tonneijck L; Smits MM; Muskiet MHA; Hoekstra T; Kramer MHH; Danser AHJ; Diamant M; Joles JA; van Raalte DH
    Diabetologia; 2016 Jul; 59(7):1412-1421. PubMed ID: 27038451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
    Rüster C; Wolf G
    Semin Nephrol; 2013 Jan; 33(1):44-53. PubMed ID: 23374893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men.
    Krikken JA; Lely AT; Bakker SJ; Navis G
    Kidney Int; 2007 Feb; 71(3):260-5. PubMed ID: 17091123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMI, nephroangiosclerosis and glomerulonephritis: Is there any meeting point?
    Gigante A; Giannakakis K; Di Mario F; Barbano B; Rosato E; Pofi R; Di Paolo M; Rocca AR; Cianci R
    Nephrology (Carlton); 2018 Nov; 23(11):991-996. PubMed ID: 28817218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The predictive value of CRP levels on future severe renal disease in overweight and obese subjects without diabetes mellitus and hypertension.
    Gülcan E; Gulcan A; Erbilen E; Taser F; Sahin L; Ozbek O; Bicik Z
    Am J Med Sci; 2007 Dec; 334(6):444-51. PubMed ID: 18091366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D status in renal transplant recipients living in a low-latitude city: association with body fat, cardiovascular risk factors, estimated glomerular filtration rate and proteinuria.
    Rosina KTC; Menna Barreto APM; Pontes KSS; Martins CJM; Souza E; Bregman R; Barreto Silva MI; Klein MRST
    Br J Nutr; 2017 May; 117(9):1279-1290. PubMed ID: 28592350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrological aspects of surgical weight correction in morbid obesity.
    Bobkova IN; Gussaova SS; Stavrovskaya EV; Struve AV
    Ter Arkh; 2018 Jun; 90(6):98-104. PubMed ID: 30701912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interpreting different measures of glomerular filtration rate in obesity and weight loss: pitfalls for the clinician.
    Jesudason DR; Clifton P
    Int J Obes (Lond); 2012 Nov; 36(11):1421-7. PubMed ID: 22184061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.